EICHORCondition: Gastrinoma · Glucagonoma · Insulinoma · Sponsor: ECOG-ACRIN Cancer Research Group
This randomized phase II trial studies how well giving temozolomide with or without capecitabine works in treating patients with advanced pancreatic neuroendocrine tumors. Drugs used in chemotherapy, such as temozolomide and capecitabine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known whether temozolomide is more effective with or without capecitabine in treating patients with advanced pancreatic neuroendocrine tumors.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Kaiser Anaheim Medical Center | Anaheim, California, United States | — |
| Kaiser Permanente-Deer Valley Medical Center | Antioch, California, United States | — |
| Kaiser Permanente Medical Group - Baldwin Park | Baldwin Park, California, United States | — |
| Kaiser Foundation Hospital | Bellflower, California, United States | — |
| Alta Bates Summit Medical Center-Herrick Campus | Berkeley, California, United States | — |
| Mills - Peninsula Hospitals | Burlingame, California, United States | — |
| Kaiser Permanente Hospital | Fontana, California, United States | — |
| Kaiser Permanente, Fremont | Fremont, California, United States | — |
| Kaiser Permanente | Fresno, California, United States | — |
| Kaiser Permanente - Harbor City | Harbor City, California, United States | — |
| Kaiser Permanente, Hayward | Hayward, California, United States | — |
| Southern California Permanente Medical Group | Irvine, California, United States | — |
+ 311 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT01824875